Multiple Sclerosis (MS) News: Breaking Multiple Sclerosis (MS) News, Comments and Articles. - Page: 5

United Spinal Secures Victory in Protecting Access to Complex Rehab Technology in Washington State

Wash State signs bill w help frm @unitedspinal assuring access to fitted #wheelchairs fr people w #disabilities http://ow.ly/kTNuE NEW YORK, May 10, 2013 /PRNewswire-USNewswire/ -- -- United Spinal Association and other advocates have combined efforts to ensure that people living with disabilities in Washington State have access to properly configured wheelchairs and other mobility equipment...

PRO-ACT: Bigger and Better ALS Database Open for Mining

Bio-IT World | Amyotrophic lateral sclerosis (ALS) research is getting a major boost from a newly launched Pooled Resource Open-access ALS Clinical Trials (PRO-ACT) platform, which has amassed more than 8,500 de-identified clinical patient records i...

Blocking protein expression delays onset of multiple sclerosis in mice, study says

(Medical Xpress)—Blocking the expression of just one protein in the brain delays the onset of paralysis in mice with a form of multiple sclerosis, say researchers at the School of Medicine.

Xenetic Bioscience's MS treatment moves to Phase II

Xenetic Biosciences (LON:XEN) has completed the Phase I, safety trial for its multiple sclerosis treatment MyeloXen and is now treating patients to establish dosing levels.  The Phase I trial passed without any adverse event on six healthy volu...

Researchers find a way the body can remove injured axons

Many medical issues affect nerves, from injuries in car accidents and side effects of chemotherapy to glaucoma and multiple sclerosis. The common theme in these scenarios is destruction of nerve axons, the long wires that transmit signals to other pa...

Dr. Gary M. Levin's Multiple Sclerosis Treatment Review and MS Research Revealed by SclerosisTreatment.com

Denver, Colorado (PRWEB) May 10, 2013 According to http://www.SclerosisTreatment.com researchers are looking at MS every conceivable way taught by medicine, and although the FDA has approved several drug-based treatments, there isn’t a perm...

Partnership Formed to Explore Personalized Medicine Approach for Amyotrophic Lateral Sclerosis (ALS) Treatments

SAN DIEGO, May 10, 2013 /PRNewswire-USNewswire/ -- The ALS Emergency Treatment Fund (ALS-ETF) and Denovo Biomarkers (Denovo) have announced a partnership to explore using Denovo's technology to identify potential responder groups for drugs being studied in ALS patients.  This personalized medicine approach may accelerate drug development in ALS and other life-threatening disorders....

Upcoming Catalysts Could Push ChemoCentryx To Double In 2013

ByBPD Research: Company Overview Founded in 1997, ChemoCentryx (CCXI) only recently went public in February 2012. The company currently has a pipeline of six small molecule drugs (three of which are partnered with GSK) that target specific chemokine receptors. Chemo-attractant cytokines, or chemokines, are chemical messengers involved in coordinating the body's inflammatory response to infection...

Receptos raises $72.8 million in IPO

Receptos Inc. (NASDAQ:RCPT) raised $72.8 million through the sale of 5.2 million shares at $14 in an IPO late Wednesday. Credit Suisse; Leerink; BMO Capital Markets; and Wedbush are underwriters. The price -- at the low end of Receptos' proposed $14-...

Tiger Balm Announces Singapore Sweepstakes Winners

Lucky fans receive trip for two to Singapore, Tiger Balm gift packs as prizes Tiger Balm (http://www.tigerbalm.com) today announced the winners of the Tiger Balm Singapore Sweepstakes. Sponsored by Prince of Peace Enterprises, Inc. the sole licensed U.S. distributor for all Tiger Balm products, the Tiger Balm Singapore Sweepstakes ran f...

Scientists show how nerve wiring self-destructs

Many medical issues affect nerves, from injuries in car accidents and side effects of chemotherapy to glaucoma and multiple sclerosis. The common theme in these scenarios is destruction of nerve axons, the long wires that transmit signals to other pa...

How nerve wiring self-destructs

Many medical issues affect nerves, from injuries and chemotherapy to glaucoma and multiple sclerosis. The common theme in these scenarios is destruction of nerve axons, the long wires that transmit signals to other parts of the body. Researchers have...

Acorda Therapeutics Announces Data Showing Dalfampridine Improves Motor Function in Preclinical Model of Post-Stroke Deficits Published in Stroke

Preclinical findings supported initiation of current dalfampridine clinical development program in post-stroke deficits Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that data showing treatment with dalfampridine improved motor function in a preclinical model of post-stroke deficits have been published online ahead of print on May 7th in Str...

PlacidWay Furthers Relationship with Panama-Based Stem Cell Facility

Denver, CO, May 09, 2013 --(PR.com)-- PlacidWay continues to develop relations with Stem Cell and Regenerative Medicine Panama, a facility located in Panama City, Panama. The facility focuses on regenerative medicine through the use of stem cells, and also provides treatments for Parkinson's disease, diabetes, arthrosis, joints pain, rheumatism, multiple sclerosis, autism and other metabolic...

Advance in tuberous sclerosis brain science

(Brown University) By manipulating the timing of disease-causing mutations in the brains of developing mice, Brown University researchers have found that early genetic deletions in the thalamus may play an important role in course and severity of the...

Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference

ANAHEIM, Calif., May 8, 2013 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Bank of America Merrill Lynch 2013 Healthcare Conference in Las Vegas on May 14, 2013 at 4:20 PM PT/7:20 PM ET. A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm. The re...

Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results

ALISO VIEJO, Calif., May 8, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today reported financial results for the three and six months ended March 31, 2013. (Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO) Quarterly Financial Highlights Total company net revenues of $17.4 million Gross and net NUEDEXTA® sales increased to $20.8 million and $16.5 millio...

Mapi Pharma receives US patent for Multiple Sclerosis treatment

Mapi Pharma, developer of complex bulk Active Pharmaceutical Ingredients (APIs), has been granted a US patent for a long acting depot formulation of glatiramer acetate, which is under the development as a once-a-month treatment for Multiple Sclerosis...

Neuralstem ALS Trial Investigator And Patient On Sirius XM

ROCKVILLE, Md., May 8, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Eva Feldman, MD, PhD, principal investigator of the Phase II trial using NSI-566 spinal cord-derived human neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), will be a guest on Sirius XM's Doctor Radio station, channel 81, on Thursday, May 9, 10-11am EDT....

MS Incidence Higher in Blacks?

A new study has suggested for the first time that multiple sclerosis may actually affect the black population more than whites. Medscape Medical News

Neuralstem: Anticipating More Efficacy Data From ALS Trial And Update On New Clinical Trials

By Smith On Stocks: Investment Opinion and Thesis I am continuing to recommend purchase of Neuralstem (CUR). The company has completed its first trial in humans, a 15 patient phase I trial in amyotrophic lateral sclerosis or ALS. Results of this trial have indicated that the surgical procedure used to implant the cells and the cells themselves are safe, which is the critical first step. Importan...

Almirall pays GW Pharma milestone on Sativex; reports 1st-qtr results

UK-based GW Pharmaceuticals (AIM: GWP) says that it has received commercialization approval for its cannabinoid-based prescription medicine Sativex from the authorities in Italy for the treatment of moderate to severe spasticity in multiple sclerosis...

Multiple Sclerosis Risk Higher For African Americans Than Whites

Brett Smith for redOrbit.com - Your Universe Online According to the National Multiple Sclerosis Society’s official website, MS is “more common in Caucasians of northern European ancestry” than other ethnicities. However, a new study in the journal Neurology has found that African American women in particular are far more likely to contract the disease than white men and women. Both black...

Can Doctors Diagnose MS from Blood?

I have seen the invisible arms of multiple sclerosis, a potentially devastating disease of the nervous system, touch friends, relatives and acquaintances. They perturbed the personality of a father of a close friend and left him unable to keep a job...

New Study Finds Alarming Number of Middle-Income Americans Inadequately Prepared for a Critical Illness Diagnosis

CARMEL, Ind., May 7, 2013 /PRNewswire/ -- An overwhelming majority (90%) of our nation's middle-income Americans say they are not financially prepared for a critical illness diagnosis, according to a new study released by Washington National Institute for Wellness Solutions (IWS). The study, Middle-Income America's Perspectives on Critical Illness and Financial Security, which surveyed 1,001 Amer...